{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:01:34Z","timestamp":1790791294699,"version":"4.1.0"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.204487","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T15:35:26Z","timestamp":1673969726000},"page":"492-512","source":"Crossref","is-referenced-by-count":24,"title":["Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death"],"prefix":"10.18632","volume":"15","author":[{"given":"Li-Ya","family":"Chiu","sequence":"first","affiliation":[{"name":"Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA 01821, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[{"name":"Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA 01821, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank T.","family":"Zenke","sequence":"additional","affiliation":[{"name":"Translational Innovation Platform Oncology and Immuno-Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Hesse, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andree","family":"Blaukat","sequence":"additional","affiliation":[{"name":"Translational Innovation Platform Oncology and Immuno-Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Hesse, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubomir T.","family":"Vassilev","sequence":"additional","affiliation":[{"name":"Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA 01821, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012.","volume":"11","author":"Delaney","year":"2014","journal-title":"Radiother Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine.","volume":"1","author":"Bortfeld","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease.","volume":"46","author":"Bartek","year":"2009","journal-title":"Nature"},{"key":"4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives.","volume":"4","author":"Elledge","year":"2010","journal-title":"Mol Cell"},{"key":"5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.","volume":"1","author":"Ziv","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6","doi-asserted-by":"publisher","first-page":"a012716","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases.","volume":"5","author":"Zou","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7","doi-asserted-by":"publisher","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks.","volume":"27","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.","volume":"6","author":"Jackson","year":"2017","journal-title":"Mol Cell"},{"key":"9","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.","volume":"31","author":"Elledge","year":"2007","journal-title":"Science"},{"key":"10","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","article-title":"Enhanced phosphorylation of p53 by ATM in response to DNA damage.","volume":"28","author":"Ziv","year":"1998","journal-title":"Science"},{"key":"11","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.","volume":"28","author":"Siliciano","year":"1998","journal-title":"Science"},{"key":"12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0014-5793(01)02114-7","article-title":"Pathways governing G1\/S transition and their response to DNA damage.","volume":"49","author":"Lukas","year":"2001","journal-title":"FEBS Lett"},{"key":"13","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.","volume":"2","author":"Lawrence","year":"2015","journal-title":"Clin Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.arr.2016.05.002","article-title":"Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.","volume":"3","author":"Lederman","year":"2017","journal-title":"Ageing Res Rev"},{"key":"15","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.","volume":"7","author":"Auh","year":"2011","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00262-013-1506-7","article-title":"Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells.","volume":"6","author":"Lord","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling.","volume":"45","author":"Barber","year":"2008","journal-title":"Nature"},{"key":"18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.","volume":"46","author":"Barber","year":"2009","journal-title":"Nature"},{"key":"19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.","volume":"33","author":"Chen","year":"2013","journal-title":"Science"},{"key":"20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.","volume":"4","author":"Chen","year":"2014","journal-title":"Immunity"},{"key":"21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","article-title":"Cytoplasmic chromatin triggers inflammation in senescence and cancer.","volume":"55","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei.","volume":"54","author":"Greenberg","year":"2017","journal-title":"Nature"},{"key":"23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity.","volume":"54","author":"Nowotny","year":"2017","journal-title":"Nature"},{"key":"24","doi-asserted-by":"publisher","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.","volume":"8","author":"Demaria","year":"2017","journal-title":"Nat Commun"},{"key":"25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1158\/1535-7163.MCT-12-0707","article-title":"Preclinical evaluation of a novel ATM inhibitor, KU59403,andin p53 functional and dysfunctional models of human cancer.","volume":"1","author":"Curtin","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"26","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-12-3408","article-title":"ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation.","volume":"1","author":"Temesi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.","volume":"4","author":"Wilson","year":"2018","journal-title":"Sci Adv"},{"key":"28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1158\/1535-7163.MCT-19-0474","article-title":"Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the GDNA Damage Checkpoint.","volume":"1","author":"Poon","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1158\/1535-7163.MCT-18-1394","article-title":"Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.","volume":"1","author":"Gill","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1158\/1535-7163.MCT-21-0934","article-title":"A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies.","volume":"2","author":"Blaukat","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/s0960-9822(98)70156-3","article-title":"Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells.","volume":"8","author":"Wahl","year":"1998","journal-title":"Curr Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/1541-7786.MCR-21-0612","article-title":"DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGF\u03b2\/PD-L1 Targeted Cancer Immunotherapy.","volume":"2","author":"Zenke","year":"2022","journal-title":"Mol Cancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.","volume":"42","author":"Kastan","year":"2003","journal-title":"Nature"},{"key":"34","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.","volume":"27","author":"Bonner","year":"1998","journal-title":"J Biol Chem"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Zenke, Zimmermann, Sirrenberg, Dahmen, Kirkin, Pehl, Grombacher, Wilm, Fuchss, Amendt, Vassilev, 19. . Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models. Mol Cancer Ther. 2020; 1091:Blaukat-101. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0734.","DOI":"10.1158\/1535-7163.MCT-19-0734"},{"key":"36","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/1541-7786.MCR-19-0362","article-title":"Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.","volume":"1","author":"Vassilev","year":"2019","journal-title":"Mol Cancer Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1038\/sj.onc.1202577","article-title":"The role of ATM in DNA damage responses and cancer.","volume":"1","author":"Lim","year":"1998","journal-title":"Oncogene"},{"key":"38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.","volume":"9","author":"Wang","year":"2019","journal-title":"Cancer Discov"},{"key":"39","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1038\/emboj.2013.203","article-title":"IFN\u03b2-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.","volume":"3","author":"Stark","year":"2013","journal-title":"EMBO J"},{"key":"40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.","volume":"1","author":"Torrejon","year":"2017","journal-title":"Cell Rep"},{"key":"41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/cas.13424","article-title":"PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.","volume":"10","author":"Shabbir","year":"2018","journal-title":"Cancer Sci"},{"key":"42","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.molmed.2017.10.002","article-title":"Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.","volume":"2","author":"Pistoia","year":"2017","journal-title":"Trends Mol Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and Its Ligands: \u201cOne for All, All for One\u201d.","volume":"9","author":"Santoni","year":"2018","journal-title":"Front Immunol"},{"key":"44","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.4049\/jimmunol.173.6.3653","article-title":"LFA-1 contributes an early signal for NK cell cytotoxicity.","volume":"17","author":"Long","year":"2004","journal-title":"J Immunol"},{"key":"45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/2159-8290.CD-16-0860","article-title":"Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.","volume":"7","author":"Yap","year":"2017","journal-title":"Cancer Discov"},{"key":"46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer.","volume":"1","author":"Yap","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41594-021-00654-x","article-title":"Molecular basis of human ATM kinase inhibition.","volume":"2","author":"Hopfner","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1126\/science.1108297","article-title":"ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex.","volume":"30","author":"Paull","year":"2005","journal-title":"Science"},{"key":"49","doi-asserted-by":"publisher","first-page":"19842","DOI":"10.1073\/pnas.0606343104","article-title":"p21 delays tumor onset by preservation of chromosomal stability.","volume":"10","author":"Lozano","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"50","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-19-0761","article-title":"Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.","volume":"7","author":"Kryczek","year":"2019","journal-title":"Cancer Res"},{"key":"51","doi-asserted-by":"publisher","first-page":"e139333","DOI":"10.1172\/JCI139333","article-title":"ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation.","volume":"13","author":"Li","year":"2021","journal-title":"J Clin Invest"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T15:16:47Z","timestamp":1675696607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11,29]]}},"alternative-id":["204487","36656721"],"URL":"https:\/\/doi.org\/10.18632\/aging.204487","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}